In-vitro activity of quinupristin/dalfopristin (Synercid) against isolates of Streptococcus pneumoniae, Staphylococcus aureus and Enterococcus spp. [4]

Journal of Antimicrobial Chemotherapy

Volumn 40, Issue 4, 1997, Pages 604-605

  Johnson, A P ^a   Warner, M ^a   Speller, D C E ^a  

^a CENTRAL PUBLIC HEALTH LABORATORY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; ANTIBIOTIC AGENT; DALFOPRISTIN; DALFOPRISTIN PLUS QUINUPRISTIN; QUINUPRISTIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; CONTROLLED STUDY; DILUTION; ENTEROCOCCUS; GRAM POSITIVE BACTERIUM; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STAPHYLOCOCCUS AUREUS; STRAIN DIFFERENCE; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MICROBIAL; ENTEROCOCCUS; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; VIRGINIAMYCIN;

EID: 0030670965     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/40.4.604     Document Type: Letter

References (6)